- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 10.32 Employment Agreement Lou Ferrari
- 10.33 Employment Agreement Richard Crowley
- 10.34 Employment Agreement Kenneth M. Bahrt
- 10.37 Service Agreement
- 10.38 Office Lease
- 21.1 Subsidiaries
- 23.1 Consent of KPMG
- 23.2 Consent of Mcgladrey & Pullen LLP
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 32.2 Certification of CFO Pursuant to Section 906
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statements on (i) Form S-3 (No. 333-146257 and 333-171961) and (ii) Form S-8 (No.333-36121, 333-33073, 333-33075, 333-64541, 333-87344, 333-127068 and 333-172536) of Savient Pharmaceuticals, Inc. of our report dated March 1, 2011, relating to our audits of the consolidated financial statements as of December 31, 2010 and for years ended December 31, 2010 and 2009 and the financial statement schedule for the years ended December 31, 2010 and 2009, which appears in the Annual Report on Form 10-K of Savient Pharmaceuticals, Inc. for the year ended December 31, 2011.
/s/ McGladrey & Pullen, LLP
New York, NY
February 29, 2012